MARKET

CHEK

CHEK

Check Cap
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5660
-0.0280
-4.71%
Closed 19:59 08/12 EDT
OPEN
0.6000
PREV CLOSE
0.5940
HIGH
0.6000
LOW
0.5602
VOLUME
4.40M
TURNOVER
--
52 WEEK HIGH
2.370
52 WEEK LOW
0.4400
MARKET CAP
26.17M
P/E (TTM)
-0.3464
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CHEK stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.

EPS

CHEK News

More
Check-Cap Reports Second Quarter 2020 Financial Results and Corporate Highlights
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they m
PR Newswire · 6d ago
Seeking Alpha Catalyst Watch
Seeking Alpha · 07/24 19:06
Exercise of warrants pressures Check-Cap, down 17%
Check-Cap (CHEK -16.7%) has entered into an agreement for exercising certain O/S warrants to purchase up to 16.05M of its ordinary shares at a reduced exer
seekingalpha · 07/23 18:56
Check-Cap Announces Exercise of Warrants For $9.6M Gross Proceeds
Benzinga · 07/23 13:37
Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before the
PR Newswire · 07/23 13:35
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 07/06 09:18
We're A Little Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Rate
Simply Wall St. · 06/07 13:01
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification
PR Newswire · 06/05 21:05

Industry

Biotechnology & Medical Research
+0.80%
Pharmaceuticals & Medical Research
+1.79%

Hot Stocks

Symbol
Price
%Change

About CHEK

Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
More

Webull offers kinds of Check Cap Ltd stock information, including NASDAQ:CHEK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHEK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHEK stock methods without spending real money on the virtual paper trading platform.